Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
- PMID: 31422551
- DOI: 10.1007/s40261-019-00839-9
Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
Abstract
The original version of this article unfortunately contained some mistakes. The corrected details are provided below.
Erratum for
-
Glucagon-Like Peptide-1 Receptor Analogues in Type 2 Diabetes: Their Use and Differential Features.Clin Drug Investig. 2019 Aug;39(8):805-819. doi: 10.1007/s40261-019-00826-0. Clin Drug Investig. 2019. PMID: 31317516 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources